GynecologyGynecology2079-56962079-5831Consilium Medicum28305Research ArticleThe importance of combined oral contraceptives use in carrying out rehabilitation actions after contacted salpingo-oophoritisUtkinE Vutkinev@mail.ru1506201416381009042020Copyright © 2014, Consilium Medicum2014In the following work the result of a non-randomized clinical research in which efficiency and acceptability of Belara® for prophylaxis and treatments of autoimmune oophoritis are presented was estimated. After 6 months of reception of a preparation reduction of the maintenance of the contents of antiovarian antibodies that allows to recommend its use to young patients with PID is ascertained.Belarasalpingo-oophoritisreproductive functionБеларасальпингоофоритрепродуктивная функция[Eckert L.O, Lentz G.M. Infections of the Lower and Upper Genital Tracts (Vulva, Vagina, Cervix, Toxic Shock Syndrome, Endometritis, and Salpingitis). Comprehensive Gynecology, 6th ed. Elsevier Inc 2013: 519-53.][Gradison M. Pelvic inflammatory disease. Am Fam Physician 2012; 85 (8): 791-6.][Derniaux E, Lucereau-Barbier M, Graesslin O. Suivi et conseils apres infections genitales hautes. J Gynecol Obstet Biol Reprod (Paris) 2012; 41 (8): 922-9.][Серов В.Н., Царегородцева М.В., Кожин А.А. Клинико - иммунологические факторы в формировании аутоиммунной овариальной недостаточности воспалительного генеза. Акуш. и гинекол. 2007; 6: 28-33.][Jaiyeoba O, Soper D.E. A practical approach to the diagnosis of pelvic inflammatory disease. Infect Dis Obstet Gynecol 2011. Special issue: Pelvic Inflammatory Disease.][Уткин Е.В. Аутоиммунные нарушения у больных с воспалительными заболеваниями придатков матки. Медицина в Кузбассе. 2008. Спецвыпуск 4; с. 113-8.][Габелова К.А., Гзгзян А.М., Богданова М.Н. и др. Применение эстрогенов и гестагенов при аутоиммунном оофорите. Журн. акушерства и женских болезней. 2003; 52, вып. 1: 49-54.][Burkman R.T. Oral contraceptives: current status. Clin Obstet Gynecol 2001; 44 (1): 62-72.][Хамошина М.Б., Савельева И.С., Зорина Е.А. и др. Послеабортная реабилитация - грани проблемы: что могут комбинированные оральные контрацептивы. Гинекология. 2013; 15 (1): 60-3.][Руководство по контрацепции. Под ред. В.Н.Прилепской. 3-е изд. М.: МЕДпресс - информ, 2014.][Zahradnik H.P, Hanjalic-Beck A. Efficacy, safety and sustainability of treatment continuation and results of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg chlormadinone acetate, in long - term usage (up to 45 cycles)-an open - label, prospective, noncontrolled, office - based Phase III study. Contraception 2008; 77 (5): 337-43.][Albenc-Gelas M, Plu-Beruau G, Guillonneau S et al. Impact of progestagen on activated protein C (APC) resistence among users of oral contraceptives. Thromb Haemost 2004; 2 (9): 1594-600.][Bitzer J. Belara - proven benefits in daily practice. Eur J Contracept Reprod Health Care 2005; 10 (Suppl. 1): 19-25.][Schramm G.A, Schrah G. The efficacy and safety of an oral contraceptive containing chlormadinone acetate: results of a pooled analysis of noninterventional trials in adult and adolescent women. Contraception 2011; 84 (4): 390-401.]